These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26625568)

  • 21. Compounding pharmaceuticals for investigational use.
    Tamer HR; Sweet BV
    Am J Health Syst Pharm; 2002 Sep; 59(18):1716-9. PubMed ID: 12298108
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacy compounding: customizing prescription drugs.
    Nordenberg T
    FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628
    [No Abstract]   [Full Text] [Related]  

  • 23. Discretion of the Food and Drug Administration to enforce compounding rules.
    Liu W; Knox CA; Brushwood DB
    Am J Health Syst Pharm; 2013 Sep; 70(17):1538-43. PubMed ID: 23943187
    [No Abstract]   [Full Text] [Related]  

  • 24. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacist compounding vs veterinarian compounding: similarities and differences.
    Jordan DG
    J Am Vet Med Assoc; 1994 Jul; 205(2):256-60. PubMed ID: 7928593
    [No Abstract]   [Full Text] [Related]  

  • 26. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance Policy Guide on Chapter 4 Human Drugs: Section 460.200 Pharmacy Compounding.
    J Pain Palliat Care Pharmacother; 2003; 17(1):99-106. PubMed ID: 14640347
    [No Abstract]   [Full Text] [Related]  

  • 28. The Drug Quality and Security Act--mind the gaps.
    Outterson K
    N Engl J Med; 2014 Jan; 370(2):97-9. PubMed ID: 24369048
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA Expands List of "Do Not Compound" Drug Products.
    Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):76-78. PubMed ID: 28287350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Registrations of compounding outsourcing facilities trickle in.
    Thompson CA
    Am J Health Syst Pharm; 2014 Mar; 71(5):350, 352. PubMed ID: 24534584
    [No Abstract]   [Full Text] [Related]  

  • 31. New England Compounding Center Indictment.
    Cabaleiro J
    Int J Pharm Compd; 2015; 19(2):94-102. PubMed ID: 26685489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. States boards of pharmacy compounding guidelines.
    Work DR
    J Am Vet Med Assoc; 1994 Jul; 205(2):254-5. PubMed ID: 7928592
    [No Abstract]   [Full Text] [Related]  

  • 33. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 35. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 36. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance policy guide addresses prescription drug compounding.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611176
    [No Abstract]   [Full Text] [Related]  

  • 38. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 39. Problems associated with veterinary compounding in swine practice.
    McKean JD
    J Am Vet Med Assoc; 1994 Jul; 205(2):279-83. PubMed ID: 7928598
    [No Abstract]   [Full Text] [Related]  

  • 40. Legal restrictions on compounding.
    Geyer RE
    J Am Vet Med Assoc; 1994 Jul; 205(2):241-2. PubMed ID: 7928588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.